Glycogen synthase kinase-3β (GSK-3β) is a downstream target of oncogenic KRas and can accumulate in the nucleus in pancreatic ductal adenocarcinoma (PDA). The gene discussed is GSK3B; the disease is pancreatic ductal adenocarcinoma.